Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 385402, 12 pages
http://dx.doi.org/10.1155/2015/385402
Research Article

Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis

1Laboratory of Mycobacterial Immunity and Pathogenesis, Rutgers, The State University of New Jersey, 225 Warren Street, Newark, NJ 07103, USA
2Public Health Research Institute at Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, 225 Warren Street, Newark, NJ 07103, USA

Received 31 July 2014; Accepted 17 September 2014

Academic Editor: Vishwanath Venketaraman

Copyright © 2015 Selvakumar Subbian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Rodriguez, “Control of iron metabolism in Mycobacterium tuberculosis,” Trends in Microbiology, vol. 14, no. 7, pp. 320–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Prados-Rosales, B. C. Weinrick, D. G. Piqué, W. R. Jacobs Jr., A. Casadevall, and G. M. Rodriguez, “Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition,” Journal of Bacteriology, vol. 196, no. 6, pp. 1250–1256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Pandey and G. M. Rodriguez, “A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice,” Infection and Immunity, vol. 80, no. 10, pp. 3650–3659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-S. Koo, S. Subbian, and G. Kaplan, “Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages,” Cell Communication and Signaling, vol. 10, article 2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Averbuch, A. Chapgier, S. Boisson-Dupuis, J.-L. Casanova, and D. Engelhard, “The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1,” Pediatric Infectious Disease Journal, vol. 30, no. 4, pp. 352–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Condos, B. Raju, A. Canova et al., “Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients,” Infection and Immunity, vol. 71, no. 4, pp. 2058–2064, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Tomlinson, T. J. Cashmore, P. T. G. Elkington et al., “Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test,” European Journal of Immunology, vol. 41, no. 11, pp. 3253–3260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Subbian, N. Bandyopadhyay, L. Tsenova et al., “Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits,” Cell Communication and Signaling, vol. 11, no. 1, article 60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kiss, Z. Czimmerer, and L. Nagy, “The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: from physiology to pathology,” Journal of Allergy and Clinical Immunology, vol. 132, no. 2, pp. 264–286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Mahajan, H. K. Dkhar, V. Chandra et al., “Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARγ and TR4 for survival,” Journal of Immunology, vol. 188, no. 11, pp. 5593–5603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Hunter, “Pathology of post primary tuberculosis of the lung: an illustrated critical review,” Tuberculosis, vol. 91, no. 6, pp. 497–509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Sand, L. Larsen, C. Hogaboam et al., “MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis—validation of two novel biomarker assays,” PLoS ONE, vol. 8, no. 12, Article ID e84934, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Fan, A. Takawale, R. Basu et al., “Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction,” Cardiovascular Research, vol. 103, no. 2, pp. 268–280, 2014. View at Publisher · View at Google Scholar
  14. K. E. Nakken, S. Nygård, T. Haaland et al., “Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/-) mice harbouring chronic cholangitis,” Scandinavian Journal of Gastroenterology, vol. 42, no. 10, pp. 1245–1255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Chen and J. K. Kolls, “T cell-mediated host immune defenses in the lung,” Annual Review of Immunology, vol. 31, pp. 605–633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Cooper, “Cell-mediated immune responses in tuberculosis,” Annual Review of Immunology, vol. 27, pp. 393–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Cooper and S. A. Khader, “The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis,” Immunological Reviews, vol. 226, no. 1, pp. 191–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. I. S. Leal, B. Smedegård, P. Andersen, and R. Appelberg, “Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-γ generation,” Immunology, vol. 104, no. 2, pp. 157–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. C. Cowley and K. L. Elkins, “CD4+ T cells mediate IFN-γ-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo,” The Journal of Immunology, vol. 171, no. 9, pp. 4689–4699, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Gallegos, J. W. J. van Heijst, M. Samstein, X. Su, E. G. Pamer, and M. S. Glickman, “A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo,” PLoS Pathogens, vol. 7, no. 5, Article ID e1002052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Gil, I. Díaz, C. Vilaplana et al., “Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs,” PLoS ONE, vol. 5, no. 4, Article ID e10030, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Ordway, C. A. Shanley, M. L. Caraway et al., “Evaluation of standard chemotherapy in the guinea pig model of tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 5, pp. 1820–1833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-F. Marquis, A. Nantel, R. LaCourse, L. Ryan, R. J. North, and P. Gros, “Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice,” Infection and Immunity, vol. 76, no. 1, pp. 78–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Cyktor, B. Carruthers, R. A. Kominsky, G. L. Beamer, P. Stromberg, and J. Turner, “IL-10 inhibits mature fibrotic granuloma formation during mycobacterium tuberculosis infection,” Journal of Immunology, vol. 190, no. 6, pp. 2778–2790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. T. A. Wynn, “Fibrotic disease and the TH1/TH2 paradigm,” Nature Reviews Immunology, vol. 4, no. 8, pp. 538–594, 2004. View at Publisher · View at Google Scholar
  26. M. G. Nair, I. J. Gallagher, M. D. Taylor et al., “Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells,” Infection and Immunity, vol. 73, no. 1, pp. 385–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Welch, L. Escoubet-Lozach, D. B. Sykes, K. Liddiard, D. R. Greaves, and C. K. Glass, “TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism,” The Journal of Biological Chemistry, vol. 277, no. 45, pp. 42821–42829, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Arora, L. Chen, M. Paglia et al., “Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7777–7782, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Liu, S. Guo, J. M. Hibbert et al., “CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications,” Cytokine & Growth Factor Reviews, vol. 22, no. 3, pp. 121–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-S. Lee, J.-Y. Lee, J. W. Son et al., “Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis,” Scandinavian Journal of Immunology, vol. 67, no. 1, pp. 77–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Treede, A. Braun, R. Sparla et al., “Anti-inflammatory effects of phosphatidylcholine,” The Journal of Biological Chemistry, vol. 282, no. 37, pp. 27155–27164, 2007. View at Publisher · View at Google Scholar · View at Scopus